Article Information
History
- January 20, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Morgan M. Stanton1,
- Sara Modan1,
- Patrick M. Taylor1,
- Harsh N. Hariani1,
- Jordan Sorokin1,
- Brian G. Rash1,
- Sneha B. Rao1,
- Alejandro López-Tobón1,
- Luigi Enriquez1,
- Brenda Dang1,
- Dorah Owango1,
- Shannon O’Neill1,
- Carlos Castrillo1,
- Justin Nicola1,
- Kathy Ye1,
- Robert M. Blattner1,
- Federico Gonzalez1,
- Dexter Antonio1,
- Pavan Ramkumar1,
- Andy Lash1,
- Douglas Flanzer1,
- Sophia Bardehle2,
- Stefka Gyoneva2,
- Kevan Shah1,
- Saul Kato1,3,* and
- Gaia Skibinski1,*
- 1Herophilus Inc., 1405 Minnesota St. San Francisco, CA 94107, USA
- 2Cerevel Therapeutics, 222 Jacobs Street, Suite 200, Cambridge, MA 02141, USA
- 3Weill Institute for Neurosciences, University of California, San Francisco, CA 94158, USA
- ↵*Primary Correspondence saul{at}herophilus.com, gaia.skibinski{at}herophilus.com